JANX - Why Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday? | Benzinga
Janux Therapeutics Inc (NASDAQ:JANX) shares are trading higher following Wednesday’s reports suggesting the company is considering a possible sale following interest from larger pharmaceutical firms.
The company, which is focused on developing tumor-activated immunotherapies for cancer treatment, has engaged a financial adviser to assess its alternatives.
Bloomberg report highlights that Janux’s attractiveness lies in its innovative treatments, which are likely to attract major players in the pharmaceutical industry seeking to bolster ...